Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pharmacological approaches based on the use of inhibi...

Full description

Bibliographic Details
Main Authors: Jose J.G. Marin, Rocio I.R. Macias, Maria J. Monte, Marta R. Romero, Maitane Asensio, Anabel Sanchez-Martin, Candela Cives-Losada, Alvaro G. Temprano, Ricardo Espinosa-Escudero, Maria Reviejo, Laura H. Bohorquez, Oscar Briz
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
apoptosis
cancer stem cell
DNA repair
epithelial-mesenchymal transition
liver cancer
metabolism
Online Access:https://www.mdpi.com/2072-6694/12/6/1663

Internet

https://www.mdpi.com/2072-6694/12/6/1663

Similar Items